From The Genomics Revolution To The Next Frontier In Biology With The CEO Of Cellanome

Recorded on 08/25/26

In this episode, we sat down with Omead Ostadan, CEO of Cellanome, and one of the key leaders behind the genomics revolution. Drawing on nearly three decades spanning Solexa, Illumina, and now Cellanome, Omead shares his perspective on the future of biological innovation, the intersection of AI and biology, and why larger, richer biological datasets are key to unlocking the next wave of discovery. We also explore Cellanome's pioneering approach to studying living cells, lessons from building category-defining companies, and where the next major breakthroughs in life sciences may emerge.